Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001571049-15-001304
Filing Date
2015-02-20
Accepted
2015-02-20 17:10:10
Documents
1
Period of Report
2015-02-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 t1500406_x3-f4.html 4  
1 FORM 4 t1500406_x3-f4.xml 4 4161
  Complete submission text file 0001571049-15-001304.txt   5783
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Issuer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CYCLACEL PHARMACEUTICALS, INC. 200 CONNELL DRIVE, SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address
Rombotis Spiro George (Reporting) CIK: 0001357396 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50626 | Film No.: 15636636